Part I. General Provisions
18VAC110-20-10. Definitions.
In addition to words and terms defined in §§ 54.1-3300 and 54.1-3401 of the Code of Virginia, the following words and terms when used in this chapter shall have the following meanings, unless the context clearly indicates otherwise:
"Acquisition" of an existing entity permitted, registered, or licensed by the board means (i) the purchase or transfer of all or substantially all of the assets of the entity or of any corporation that owns or controls the entity; (ii) the creation of a partnership by a sole proprietor or change in partnership composition; (iii) the acquiring of 50% or more of the outstanding shares of voting stock of a corporation owning the entity or of the parent corporation of a wholly owned subsidiary owning the entity, except that this shall not apply to any corporation the voting stock of which is actively traded on any securities exchange or in any over-the-counter market; or (iv) the merger of a corporation owning the entity or of the parent corporation of a wholly owned subsidiary owning the entity with another business or corporation.
"Actively reports" means reporting all dispensing errors and analyses of such errors to a patient safety organization as soon as practical or at least within 30 days of identifying the error.
"Alternate delivery site" means a location authorized in 18VAC110-20-275 to receive dispensed prescriptions on behalf of and for further delivery or administration to a patient.
"Analysis" means a review of the findings collected and documented on each dispensing error, assessment of the cause and any factors contributing to the dispensing error, and any recommendation for remedial action to improve pharmacy systems and workflow processes to prevent or reduce future errors.
"Authorized collector" means a narcotic treatment program, hospital or clinic with an on-site pharmacy, or pharmacy that is authorized by the U.S. Drug Enforcement Administration to receive drugs for the purpose of destruction.
"Beyond-use date" means the date beyond which the integrity of a compounded, repackaged, or dispensed drug can no longer be assured and as such is deemed to be adulterated or misbranded as defined in §§ 54.1-3461 and 54.1-3462 of the Code of Virginia.
"Board" means the Virginia Board of Pharmacy.
"Chart order" means a lawful order for a drug or device entered on the chart or in a medical record of a patient by a prescriber or the prescriber's designated agent.
"Compliance packaging" means packaging for dispensed drugs that is comprised of a series of containers for solid oral dosage forms and designed to assist the user in administering or self-administering the drugs in accordance with directions for use.
"Correctional facility" means any prison, penitentiary, penal facility, jail, detention unit, or other facility in which persons are incarcerated by government officials.
"DEA" means the U.S. Drug Enforcement Administration.
"Dispensing error" means one or more of the following discovered after the final verification by the pharmacist, regardless of whether the patient received the drug:
1. Variation from the prescriber's prescription drug order, including:
a. Incorrect drug;
b. Incorrect drug strength;
c. Incorrect dosage form;
d. Incorrect patient; or
e. Inadequate or incorrect packaging, labeling, or directions.
2. Failure to exercise professional judgment in identifying and managing:
a. Known therapeutic duplication;
b. Known drug-disease contraindications;
c. Known drug-drug interactions;
d. Incorrect drug dosage or duration of drug treatment;
e. Known drug-allergy interactions;
f. A clinically significant, avoidable delay in therapy; or
g. Any other significant, actual, or potential problem with a patient's drug therapy.
3. Delivery of a drug to the incorrect patient.
4. Variation in bulk repackaging or filling of automated devices, including:
a. Incorrect drug;
b. Incorrect drug strength;
c. Incorrect dosage form; or
d. Inadequate or incorrect packaging or labeling.
"Drug donation site" means a permitted pharmacy that specifically registers with the board for the purpose of receiving or redispensing eligible donated prescription drugs pursuant to § 54.1-3411.1 of the Code of Virginia.
"Electronic prescription" means a written prescription that is generated on an electronic application and is transmitted to a pharmacy as an electronic data file; Schedules II through V prescriptions shall be transmitted in accordance with 21 CFR Part 1300.
"EMS" means emergency medical services.
"Expiration date" means that date placed on a drug package by the manufacturer or repacker beyond which the product may not be dispensed or used.
"Faxed prescription" means a written prescription or order that is transmitted by an electronic device that sends over telephone lines the exact image to the receiver (pharmacy) in a hard copy form.
"FDA" means the U.S. Food and Drug Administration.
"Floor stock" means a supply of drugs that have been distributed for the purpose of general administration by a prescriber or other authorized person pursuant to a valid order of a prescriber.
"Forgery" means a prescription that was falsely created, falsely signed, or altered.
"Generic drug name" means the nonproprietary name listed in the United States Pharmacopeia-National Formulary (USP-NF) or in the United States Adopted Names (USAN) and the USP Dictionary of Drug Names.
"Hospital" or "nursing home" means those facilities as defined in Title 32.1 of the Code of Virginia or as defined in regulations by the Virginia Department of Health.
"Initials" means the first letters of a person's name or other unique personal identifier.
"Long-term care facility" means a nursing home, retirement care, mental care, or other facility or institution that provides extended health care to resident patients.
"NABP" means the National Association of Boards of Pharmacy.
"Nuclear pharmacy" means a pharmacy providing radiopharmaceutical services.
"On duty" means that a pharmacist is on the premises at the address of the permitted pharmacy and is available as needed.
"On-hold prescription" means a valid prescription that is received and maintained at the pharmacy for initial dispensing on a future date.
"Patient safety organization" means an organization that has as its primary mission continuous quality improvement under the Patient Safety and Quality Improvement Act of 2005 (P.L. 109-41) and is credentialed by the Agency for Healthcare Research and Quality.
"Permitted physician" means a physician who is licensed pursuant to § 54.1-3304 of the Code of Virginia to dispense drugs to persons to whom or for whom pharmacy services are not reasonably available.
"Perpetual inventory" means an ongoing system for recording quantities of drugs received, dispensed, or otherwise distributed by a pharmacy.
"Personal supervision" means the pharmacist must be physically present and render direct, personal control over the entire service being rendered or act being performed. Neither prior nor future instructions shall be sufficient nor shall supervision rendered by telephone, written instructions, or by any mechanical or electronic methods be sufficient.
"Pharmacy closing" means that the permitted pharmacy ceases pharmacy services or fails to provide for continuity of pharmacy services or lawful access to patient prescription records or other required patient records for the purpose of continued pharmacy services to patients.
"PIC" means the pharmacist-in-charge of a permitted pharmacy.
"Practice location" means any location in which a prescriber evaluates or treats a patient.
"Prescription department" means any contiguous or noncontiguous areas used for the compounding, dispensing, and storage of all Schedules II through VI drugs and devices and any Schedule I investigational drug.
"Quality assurance plan" means a plan approved by the board for ongoing monitoring, measuring, evaluating, and, if necessary, improving the performance of a pharmacy function or system.
"Radiopharmaceutical" means any drug that exhibits spontaneous disintegration of unstable nuclei with the emission of nuclear particles or photons and includes any nonradioactive reagent kit or radionuclide generator that is intended to be used in the preparation of any such substance but does not include drugs such as carbon-containing compounds or potassium-containing salts that include trace quantities of naturally occurring radionuclides. The term also includes any biological product that is labeled with a radionuclide or intended solely to be labeled with a radionuclide.
"Repackaged drug" means any drug removed from the manufacturer's original package and placed in different packaging.
"Robotic pharmacy system" means a mechanical system controlled by a computer that performs operations or activities relative to the storage, packaging, compounding, labeling, dispensing, or distribution of medications and collects, controls, and maintains all transaction information.
"Safety closure container" means a container that meets the requirements of the federal Poison Prevention Packaging Act of 1970 (15 USC §§ 1471‑1476), that is, in testing such containers, that 85% of a test group of 200 children of ages 41-52 months are unable to open the container in a five-minute period and that 80% fail in another five minutes after a demonstration of how to open it and that 90% of a test group of 100 adults must be able to open and close the container.
"Satellite pharmacy" means a pharmacy that is noncontiguous to the centrally permitted pharmacy of a hospital but at the location designated on the pharmacy permit.
"Special packaging" means packaging that is designed or constructed to be significantly difficult for children younger than five years of age to open to obtain a toxic or harmful amount of the drug contained therein within a reasonable time and not difficult for normal adults to use properly but does not mean packaging that all such children cannot open or obtain a toxic or harmful amount within a reasonable time.
"Special use permit" means a permit issued to conduct a pharmacy of a special scope of service that varies in any way from the provisions of any board regulation.
"Storage temperature" means those specific directions stated in some monographs with respect to the temperatures at which pharmaceutical articles shall be stored, where it is considered that storage at a lower or higher temperature may produce undesirable results. The conditions are defined by the following terms:
1. "Cold" means any temperature not exceeding 8°C (46°F). A refrigerator is a cold place in which temperature is maintained thermostatically between 2° and 8°C (36° and 46°F). A freezer is a cold place in which the temperature is controlled between ‑25° and ‑10°C (‑13° and 14°F). In those instances in which articles may have a recommended storage condition below ‑20°C (‑4°F), the temperature of the storage location should be controlled to plus or minus 10 degrees.
2. "Room temperature" means the temperature prevailing in a working area.
3. "Controlled room temperature" means a temperature maintained thermostatically that encompasses the usual and customary working environment of 20° to 25°C (68° to 77°F); that results in a mean kinetic temperature calculated to be not more than 25°C (77°F); and that allows for excursions between 15° and 30°C (59° and 86°F) that are experienced in pharmacies, hospitals, and warehouses.
4. "Warm" means any temperature between 30° and 40°C (86° and 104°F).
5. "Excessive heat" means any temperature above 40°C (104°F).
6. "Protection from freezing" means where, in addition to the risk of breakage of the container, freezing subjects a product to loss of strength or potency or to the destructive alteration of its characteristics, the container label bears an appropriate instruction to protect the product from freezing.
7. "Cool" means any temperature between 8° and 15°C (46° and 59°F).
"Terminally ill" means a patient with a terminal condition as defined in § 54.1-2982 of the Code of Virginia.
"Ultimate user" means a person who has lawfully obtained, and who possesses, a controlled substance for his own use or for the use of a member of his household or for an animal owned by him or a member of his household.
"Unit dose container" means a container that is a single-unit container, as defined in United States Pharmacopeia-National Formulary, for articles intended for administration by other than the parenteral route as a single dose, direct from the container.
"Unit dose package" means a container that contains a particular dose ordered for a patient.
"Unit dose system" means a system in which multiple drugs in unit dose packaging are dispensed in a single container, such as a medication drawer or bin, labeled only with patient name and location. Directions for administration are not provided by the pharmacy on the drug packaging or container but are obtained by the person administering directly from a prescriber's order or medication administration record.
"USP-NF" means the United States Pharmacopeia-National Formulary.
"Well-closed container" means a container that protects the contents from extraneous solids and from loss of the drug under the ordinary or customary conditions of handling, shipment, storage, and distribution.
Statutory Authority
§§ 54.1-2400 and 54.1-3307 of the Code of Virginia.
Historical Notes
Derived from VR530-01-1 § 1.1, eff. October 25, 1989; amended, Virginia Register Volume 9, Issue 4, eff. December 16, 1992; Volume 10, Issue 1, eff. November 4, 1993; Volume 11, Issue 21, eff. August 9, 1995; Volume 12, Issue 21, eff. August 7, 1996; Volume 15, Issue 8, eff. February 3, 1999; Volume 15, Issue 26, eff. October 13, 1999; Volume 16, Issue 21, eff. August 2, 2000; Volume 17, Issue 7, eff. January 17, 2001; Volume 20, Issue 23, eff. August 25, 2004; Volume 24, Issue 8, eff. January 23, 2008; Volume 25, Issue 24, eff. September 2, 2009; Volume 26, Issue 22, eff. August 4, 2010; Volume 27, Issue 3, eff. November 10, 2010; Volume 30, Issue 10, eff. February 12, 2014; Volume 31, Issue 7, eff. December 31, 2014; Volume 31, Issue 20, eff. July 16, 2015; Volume 32, Issue 12, eff. March 24, 2016; Volume 35, Issue 21, eff. July 25, 2019; Volume 36, Issue 6, eff. December 11, 2019.
18VAC110-20-15. (Repealed.)
Historical Notes
Derived from Virginia Register Volume 21, Issue 15, eff. May 4, 2005; repealed, Virginia Register Volume 36, Issue 6, eff. December 11, 2019.
18VAC110-20-20. Fees.
A. Unless otherwise provided, fees listed in this section shall not be refundable.
B. Initial application fees.
1. Pharmacy permit | $500 |
2. Permitted physician licensed to dispense drugs | $500 |
3. Medical equipment supplier permit | $235 |
4. Outsourcing facility permit | $350 |
5. Nonresident pharmacy registration | $350 |
6. Nonresident outsourcing facility registration | $350 |
7. Controlled substances registrations | $120 |
8. Innovative program approval. | $325 |
If the board determines that a technical consultant is required in order to make a decision on approval, any consultant fee, not to exceed the actual cost, shall also be paid by the applicant in addition to the application fee. | |
9. Approval of a repackaging training program | $65 |
C. Annual renewal fees.
1. Pharmacy permit – due no later than April 30 | $350 |
2. Physician permit to practice pharmacy – due no later than February 28 | $350 |
3. Medical equipment supplier permit – due no later than February 28 | $235 |
4. Outsourcing facility permit – due no later than April 30 | $350 |
5. Nonresident pharmacy registration – due no later than the date of initial registration | $350 |
6. Nonresident outsourcing facility registration – due no later than the date of initial registration | $350 |
7. Controlled substances registrations – due no later than February 28 | $120 |
8. Innovative program continued approval based on board order not to exceed $260 per approval period. | |
9. Repackaging training program | $40 every two years |
D. Late fees. The following late fees shall be paid in addition to the current renewal fee to renew an expired permit or registration within one year of the expiration date. In addition, engaging in activities requiring a permit or registration after the expiration date of such permit or registration shall be grounds for disciplinary action by the board.
1. Pharmacy permit | $120 |
2. Physician permit to practice pharmacy | $120 |
3. Medical equipment supplier permit | $80 |
4. Outsourcing facility permit | $120 |
5. Nonresident pharmacy registration | $120 |
6. Nonresident outsourcing facility registration | $120 |
7. Controlled substances registrations | $40 |
8. Repackaging training program | $15 |
E. Reinstatement fees.
1. Any person or entity attempting to renew a permit or registration more than one year after the expiration date shall submit an application for reinstatement with any required fees. Reinstatement is at the discretion of the board and, except for reinstatement following revocation or suspension, may be granted by the executive director of the board upon completion of an application and payment of any required fees.
2. Facilities or entities that cease operation and wish to resume shall not be eligible for reinstatement but shall apply for a new permit or registration. Facilities or entities that failed to renew and continued to operate for more than one renewal cycle shall pay the current and all back renewal fees for the years in which they were operating plus the following reinstatement fees:
a. Pharmacy permit | $315 | |
b. Physician permit to practice pharmacy | $315 | |
c. Medical equipment supplier permit | $275 | |
d. Outsourcing facility permit | $315 | |
e. Nonresident pharmacy registration | $150 | |
f. Nonresident outsourcing facility registration | $315 | |
g. Controlled substances registration | $235 | |
h. Repackaging training program | $65 |
F. Application for change or inspection fees for facilities or other entities.
1. Change of pharmacist-in-charge | $65 |
2. Change of ownership for any facility | $65 |
3. Inspection for remodeling or change of location for any facility | $300 |
4. Reinspection of any facility | $300 |
5. Board-required inspection for a robotic pharmacy system | $300 |
6. Board-required inspection of an innovative program location | $300 |
7. Change of pharmacist responsible for an approved innovative program | $35 |
G. Miscellaneous fees.
1. Handling fee for returned check or a dishonored credit card or debit card | $50 |
2. Duplicate permit or registration | $15 |
3. Verification of permit or registration | $35 |
Statutory Authority
§§ 54.1-2400 and 54.1-3307 of the Code of Virginia.
Historical Notes
Derived from VR530-01-1 § 1.2, eff. October 25, 1989; amended, Virginia Register Volume 9, Issue 4, eff. December 16, 1992; Volume 10, Issue 1, eff. November 4, 1993; Volume 11, Issue 21, eff. August 9, 1995; Volume 12, Issue 21, eff. August 7, 1996; Volume 15, Issue 8, eff. February 3, 1999; Volume 17, Issue 7, eff. January 17, 2001; Volume 18, Issue 12, eff. March 27, 2002; Volume 19, Issue 4, eff. December 4, 2002; Volume 19, Issue 10, eff. February 26, 2003; Volume 20, Issue 23, eff. August 25, 2004; Volume 22, Issue 2, eff. November 2, 2005; Volume 22, Issue 15, eff. May 3, 2006; Volume 22, Issue 24, eff. September 6, 2006; Errata 22:25 VA.R. 3935 August 21, 2006; amended, Virginia Register Volume 23, Issue 4, eff. November 29, 2006; Volume 25, Issue 24, eff. September 2, 2009; Volume 26, Issue 2, eff. October 28, 2009; Errata, 26:5 VA.R. 510 November 9, 2009; amended, Virginia Register Volume 26, Issue 6, eff. December 23, 2009; Volume 28, Issue 23, eff. August 15, 2012; Volume 29, Issue 25, eff. September 26, 2013; Volume 31, Issue 20, eff. July 16, 2015; Volume 33, Issue 20, eff. June 28, 2017; Volume 36, Issue 6, eff. December 11, 2019; Volume 37, Issue 12, eff. March 18, 2021.
18VAC110-20-21. (Repealed.)
Historical Notes
Derived from Virginia Register Volume 25, Issue 17, eff. July 1, 2009; repealed, Virginia Register Volume 36, Issue 6, eff. December 11, 2019.
18VAC110-20-22. (Repealed.)
Historical Notes
Derived from Virginia Register Volume 35, Issue 20, eff. June 26, 2019; repealed, Virginia Register Volume 36, Issue 6, eff. December 11, 2019.
18VAC110-20-25. Unprofessional conduct.
The following practices shall constitute unprofessional conduct within the meaning of § 54.1-3316 of the Code of Virginia:
1. Failing to comply with provisions of § 32.1-127.1:03 of the Code of Virginia related to the confidentiality and disclosure of patient records or related to provision of patient records to another practitioner or to the patient or the patient's personal representative;
2. Willfully or negligently breaching the confidentiality of a patient unless otherwise required or permitted by applicable law;
3. Failing to maintain confidentiality of information received from the Prescription Monitoring Program, obtaining such information for reasons other than to assist in determining the validity of a prescription to be filled, or misusing information received from the program;
4. Failing to maintain adequate safeguards against diversion of controlled substances;
5. Failing to appropriately respond to a known dispensing error in a manner that protects the health and safety of the patient;
6. Delegating a task within the practice of pharmacy to a person who is not adequately trained to perform such a task;
7. Failing by the PIC to ensure that pharmacy interns and pharmacy technicians working in the pharmacy are registered and that such registration is current;
8. Obtaining money or property of a patient or client by fraud or misrepresentation;
9. Providing false information or failing to cooperate with an employee of the Department of Health Professions in the conduct on an investigation or inspection;
10. Violating any provision of this chapter or Chapter 33 (§ 54.1-3300 et seq.) or 34 (§ 54.1-3400 et seq.) of Title 54.1 of the Code of Virginia;
11. Performing any act likely to deceive, defraud, or harm the public; or
12. Having a restriction of a license, permit, or registration to practice in another jurisdiction in the United States.
Statutory Authority
§§ 54.1-2400 and 54.1-3307 of the Code of Virginia.
Historical Notes
Derived from Virginia Register Volume 26, Issue 12, eff. March 17, 2010; amended, Virginia Register Volume 36, Issue 6, eff. December 11, 2019.
18VAC110-20-30. (Repealed.)
(Repealed)
Historical Notes
Derived from VR530-01-1 § 2.1, eff. October 25, 1989; amended, Virginia Register Volume 9, Issue 4, eff. December 16, 1992; Volume 10, Issue 1, eff. November 4, 1993; Volume 11, Issue 21, eff. August 9, 1995; Volume 15, Issue 8, eff. February 3, 1999; Volume 20, Issue 23, eff. August 25, 2004; Volume 25, Issue 24, eff. September 2, 2009; repealed, Virginia Register Volume 36, Issue 6, eff. December 11, 2019.
18VAC110-20-40. (Repealed.)
Historical Notes
Derived from VR530-01-1 § 2.2, eff. October 25, 1989; amended, Virginia Register Volume 9, Issue 4, eff. December 16, 1992; Volume 10, Issue 1, eff. November 4, 1993; Volume 11, Issue 21, eff. August 9, 1995; Volume 15, Issue 8, eff. February 3, 1999; Volume 20, Issue 23, eff. August 25, 2004; Volume 25, Issue 24, eff. September 2, 2009; Volume 29, Issue 25, eff. September 26, 2013; repealed, Virginia Register Volume 36, Issue 6, eff. December 11, 2019.
18VAC110-20-50. (Repealed.)
Historical Notes
Derived from VR530-01-1 § 2.3, eff. October 25, 1989; amended, Virginia Register Volume 9, Issue 4, eff. December 16, 1992; Volume 10, Issue 1, eff. November 4, 1993; Volume 11, Issue 21, eff. August 9, 1995; Volume 15, Issue 8, eff. February 3, 1999; Volume 25, Issue 24, eff. September 2, 2009; repealed, Virginia Register Volume 36, Issue 6, eff. December 11, 2019.
18VAC110-20-60. (Repealed.)
Historical Notes
Derived from VR530-01-1 § 2.4, eff. October 25, 1989; amended, Virginia Register Volume 9, Issue 4, eff. December 16, 1992; Volume 10, Issue 1, eff. November 4, 1993; Volume 11, Issue 21, eff. August 9, 1995; Volume 15, Issue 8, eff. February 3, 1999; Volume 20, Issue 23, eff. August 25, 2004; Volume 25, Issue 24, eff. September 2, 2009; repealed, Virginia Register Volume 36, Issue 6, eff. December 11, 2019.
18VAC110-20-70. (Repealed.)
Historical Notes
Derived from VR530-01-1 § 2.5, eff. August 9, 1995; amended, Virginia Register Volume 15, Issue 8, eff. February 3, 1999; Volume 20, Issue 23, eff. August 25, 2004; Volume 22, Issue 24, eff. October 23, 2006; Volume 25, Issue 24, eff. September 2, 2009; repealed, Virginia Register Volume 36, Issue 6, eff. December 11, 2019.
18VAC110-20-75. (Repealed.)
Historical Notes
Derived from Virginia Register Volume 19, Issue 19, eff. July 2, 2003; amended, Virginia Register Volume 24, Issue 22, eff. August 6, 2008; repealed, Virginia Register Volume 36, Issue 6, eff. December 11, 2019.
18VAC110-20-80. (Repealed.)
Historical Notes
Derived from VR530-01-1 § 2.6, eff. October 25, 1989; amended, Virginia Register Volume 9, Issue 4, eff. December 16, 1992; Volume 10, Issue 1, eff. November 4, 1993; Volume 11, Issue 21, eff. August 9, 1995; Volume 20, Issue 23, eff. August 25, 2004; Volume 25, Issue 24, eff. September 2, 2009; Volume 35, Issue 20, eff. June 26, 2019; repealed, Virginia Register Volume 36, Issue 6, eff. December 11, 2019.
18VAC110-20-90. (Repealed.)
Historical Notes
Derived from VR530-01-1 § 2.7, eff. October 25, 1989; amended, Virginia Register Volume 9, Issue 4, eff. December 16, 1992; Volume 10, Issue 1, eff. November 4, 1993; Volume 11, Issue 21, eff. August 9, 1995; Volume 12, Issue 21, eff. August 7, 1996; Volume 15, Issue 8, eff. February 3, 1999; Volume 20, Issue 23, eff. August 25, 2004; Volume 25, Issue 24, eff. September 2, 2009; Volume 26, Issue 22, eff. August 4, 2010; Volume 33, Issue 15, eff. May 5, 2017; repealed, Virginia Register Volume 36, Issue 6, eff. December 11, 2019.
18VAC110-20-100. (Repealed.)
Historical Notes
Derived from VR530-01-1 § 2.8, eff. October 25, 1989; amended, Virginia Register Volume 9, Issue 4, eff. December 16, 1992; Volume 10, Issue 1, eff. November 4, 1993; Volume 11, Issue 21, eff. August 9, 1995; Volume 15, Issue 8, eff. February 3, 1999; Volume 25, Issue 24, eff. September 2, 2009; repealed, Virginia Register Volume 36, Issue 6, eff. December 11, 2019.
18VAC110-20-101. (Repealed.)
(Repealed)
Historical Notes
Derived from Virginia Register Volume 19, Issue 10, eff. February 26, 2003; amended, Virginia Register Volume 25, Issue 24, eff. September 2, 2009; repealed, Virginia Register Volume 36, Issue 6, eff. December 11, 2019.
18VAC110-20-102. (Repealed.)
Historical Notes
Derived from Virginia Register Volume 19, Issue 10, eff. February 26, 2003; amended, Virginia Register Volume 25, Issue 24, eff. September 2, 2009; repealed, Virginia Register Volume 36, Issue 6, eff. December 11, 2019.
18VAC110-20-103. (Repealed.)
Historical Notes
Derived from Virginia Register Volume 19, Issue 10, eff. February 26, 2003; amended, Virginia Register Volume 25, Issue 24, eff. September 2, 2009; repealed, Virginia Register Volume 36, Issue 6, eff. December 11, 2019.
18VAC110-20-104. (Repealed.)
Historical Notes
Derived from Virginia Register Volume 19, Issue 10, eff. February 26, 2003; amended, Virginia Register Volume 25, Issue 24, eff. September 2, 2009; repealed, Virginia Register Volume 36, Issue 6, eff. December 11, 2019.
18VAC110-20-105. (Repealed.)
Historical Notes
Derived from Virginia Register Volume 19, Issue 10, eff. February 26, 2003; amended, Virginia Register Volume 20, Issue 23, eff. August 25, 2004; Volume 29, Issue 25, eff. September 26, 2013; Volume 35, Issue 20, eff. June 26, 2019; repealed, Virginia Register Volume 36, Issue 6, eff. December 11, 2019.
18VAC110-20-106. (Repealed.)
Historical Notes
Derived from Virginia Register Volume 19, Issue 10, eff. February 26, 2003; amended, Virginia Register Volume 25, Issue 24, eff. September 2, 2009; Volume 26, Issue 2, eff. October 28, 2009; Volume 26, Issue 22, eff. August 4, 2010; Volume 33, Issue 15, eff. May 5, 2017; repealed, Virginia Register Volume 36, Issue 6, eff. December 11, 2019.